ROPEOK(SH:688619)2023-08-16 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥24,265,314.80, representing a year-on-year increase of 122.45%[2] - The net profit attributable to shareholders was -¥17,196,764.48, indicating a significant loss[2] - The net cash flow from operating activities was -¥61,634,705.92, reflecting ongoing cash outflows[2] - Total operating revenue for Q1 2023 was CNY 24,265,314.80, a significant increase from CNY 10,907,971.17 in Q1 2022, representing a growth of approximately 122.5%[17] - The net loss for Q1 2023 was CNY 17,479,763.45, compared to a net loss of CNY 13,425,828.86 in Q1 2022, reflecting a deterioration in performance[18] - The operating profit for Q1 2023 was reported at CNY -22,666,777.17, compared to CNY -17,051,586.19 in the same period last year[18] Cash Flow - The cash inflow from operating activities totaled $64,106,980.75, a decrease of 23.8% compared to $83,991,654.60 in Q1 2022[23] - The cash outflow from operating activities was $125,741,686.67, down from $160,006,673.67 in the same period last year, resulting in a net cash flow from operating activities of -$61,634,705.92, an improvement from -$76,015,019.07[23] - Investment activities generated a net cash inflow of $56,649,519.75, a significant recovery from a net outflow of -$379,061,998.09 in Q1 2022[23] - The cash inflow from financing activities was $59,800,000.00, a substantial increase from $1,000,000.00 in Q1 2022[24] - The net cash flow from financing activities improved to $38,778,442.09, compared to a net outflow of -$67,220,316.66 in the previous year[24] - The company reported a cash increase of $33,793,255.92 in Q1 2023, contrasting with a decrease of -$522,297,333.82 in Q1 2022[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,837,659,795.69, down 2.19% from the previous year[3] - The total assets as of Q1 2023 were CNY 1,837,659,795.69, a decrease from CNY 1,878,741,049.82 at the end of the previous period[15] - Total liabilities for Q1 2023 were CNY 629,585,493.71, down from CNY 653,186,984.39 in the previous period[15] - The total equity attributable to shareholders was CNY 1,190,482,167.73, a decrease from CNY 1,207,678,932.21 in the previous period[15] Research and Development - R&D investment totaled ¥10,681,636.01, accounting for 44.02% of operating revenue, a decrease of 46.04 percentage points compared to the previous year[3] - Research and development expenses for Q1 2023 amounted to CNY 10,681,636.01, compared to CNY 9,823,271.50 in Q1 2022, showing an increase of approximately 8.7%[18] Shareholder Information - The top shareholder, Chen Yanxing, holds 37.73% of the shares, totaling 70,801,353 shares[8] - The company held a total of 2,207,433 shares in its repurchase account, accounting for 1.18% of the total share capital[11] Operational Strategy - The company increased its sales efforts and R&D investments, leading to higher operational costs and interest expenses due to increased borrowing[6] - The company is actively expanding its business nationwide, converting orders into performance[6] - The cash flow from operating activities showed a narrowing of net outflows compared to the same period last year, driven by improved collection of accounts receivable[6] Future Outlook - The company has not provided specific guidance for future performance or new product developments in the current report[12] - There are no significant mergers or acquisitions reported during this quarter, with a focus on internal growth strategies[12]